Literature DB >> 16224021

Akt-mediated phosphorylation of EZH2 suppresses methylation of lysine 27 in histone H3.

Tai-Lung Cha1, Binhua P Zhou, Weiya Xia, Yadi Wu, Cheng-Chieh Yang, Chun-Te Chen, Bo Ping, Arie P Otte, Mien-Chie Hung.   

Abstract

Enhancer of Zeste homolog 2 (EZH2) is a methyltransferase that plays an important role in many biological processes through its ability to trimethylate lysine 27 in histone H3. Here, we show that Akt phosphorylates EZH2 at serine 21 and suppresses its methyltransferase activity by impeding EZH2 binding to histone H3, which results in a decrease of lysine 27 trimethylation and derepression of silenced genes. Our results imply that Akt regulates the methylation activity, through phosphorylation of EZH2, which may contribute to oncogenesis.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16224021     DOI: 10.1126/science.1118947

Source DB:  PubMed          Journal:  Science        ISSN: 0036-8075            Impact factor:   47.728


  272 in total

1.  Oxidation of Akt2 kinase promotes cell migration and regulates G1-S transition in the cell cycle.

Authors:  Revati Wani; N Sharmila Bharathi; Jeffrey Field; Allen W Tsang; Cristina M Furdui
Journal:  Cell Cycle       Date:  2011-10-01       Impact factor: 4.534

2.  Rapid activation of the bivalent gene Sox21 requires displacement of multiple layers of gene-silencing machinery.

Authors:  Harini Chakravarthy; Briana D Ormsbee; Sunil K Mallanna; Angie Rizzino
Journal:  FASEB J       Date:  2010-09-27       Impact factor: 5.191

3.  Genetic and epigenetic regulation of AHR gene expression in MCF-7 breast cancer cells: role of the proximal promoter GC-rich region.

Authors:  Neal A Englert; Robert J Turesky; Weiguo Han; Erin E Bessette; Simon D Spivack; Michele Caggana; David C Spink; Barbara C Spink
Journal:  Biochem Pharmacol       Date:  2012-06-21       Impact factor: 5.858

4.  Deciphering the Key Features of Malignant Tumor Microenvironment for Anti-cancer Therapy.

Authors:  Bingxue Shang; Gaochuan Zhang; Yanyan Pan; Quansheng Zhou
Journal:  Cancer Microenviron       Date:  2012-05-17

5.  Reactive oxygen species contribute to arsenic-induced EZH2 phosphorylation in human bronchial epithelial cells and lung cancer cells.

Authors:  Lingzhi Li; Ping Qiu; Bailing Chen; Yongju Lu; Kai Wu; Chitra Thakur; Qingshan Chang; Jiaying Sun; Fei Chen
Journal:  Toxicol Appl Pharmacol       Date:  2014-02-25       Impact factor: 4.219

Review 6.  EZH2: not EZHY (easy) to deal.

Authors:  Gauri Deb; Anup Kumar Singh; Sanjay Gupta
Journal:  Mol Cancer Res       Date:  2014-02-13       Impact factor: 5.852

7.  Akt phosphorylates the transcriptional repressor bmi1 to block its effects on the tumor-suppressing ink4a-arf locus.

Authors:  Yan Liu; Fan Liu; Hao Yu; Xinyang Zhao; Goro Sashida; Anthony Deblasio; Michael Harr; Qing-Bai She; Zhenbang Chen; Hui-Kuan Lin; Silvana Di Giandomenico; Shannon E Elf; Youyang Yang; Yasuhiko Miyata; Gang Huang; Silvia Menendez; Ingo K Mellinghoff; Neal Rosen; Pier Paolo Pandolfi; Cyrus V Hedvat; Stephen D Nimer
Journal:  Sci Signal       Date:  2012-10-23       Impact factor: 8.192

8.  Epithelial EZH2 serves as an epigenetic determinant in experimental colitis by inhibiting TNFα-mediated inflammation and apoptosis.

Authors:  Yongfeng Liu; Junjie Peng; Tongyu Sun; Ni Li; Le Zhang; Jiale Ren; Huairui Yuan; Shan Kan; Qiang Pan; Xiang Li; Yufeng Ding; Min Jiang; Xiaoji Cong; Minjia Tan; Yushui Ma; Da Fu; Sanjun Cai; Yichuan Xiao; Xiaoming Wang; Jun Qin
Journal:  Proc Natl Acad Sci U S A       Date:  2017-04-24       Impact factor: 11.205

9.  JNK and STAT3 signaling pathways converge on Akt-mediated phosphorylation of EZH2 in bronchial epithelial cells induced by arsenic.

Authors:  Bailing Chen; Jia Liu; Qingshan Chang; Kevin Beezhold; Yongju Lu; Fei Chen
Journal:  Cell Cycle       Date:  2012-12-19       Impact factor: 4.534

10.  KDM5B Is Essential for the Hyperactivation of PI3K/AKT Signaling in Prostate Tumorigenesis.

Authors:  Guoliang Li; Thanigaivelan Kanagasabai; Wenfu Lu; Mike R Zou; Shang-Min Zhang; Sherly I Celada; Michael G Izban; Qi Liu; Tao Lu; Billy R Ballard; Xinchun Zhou; Samuel E Adunyah; Robert J Matusik; Qin Yan; Zhenbang Chen
Journal:  Cancer Res       Date:  2020-08-31       Impact factor: 12.701

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.